New vulnerability in deadly form of lung cancer discovered
Researchers at the Children’s Medical Center Research Institute at UT Southwestern (CRI) have discovered a new metabolic vulnerability in small […]
Researchers at Karolinska Institutet, Sweden, and the University of Sussex, England, have discovered that the process of copying DNA generates […] Fighting cancer means killing cancer cells. However, oncologists know that it’s also important to halt the movement of cancer cells […] A new study in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that recent-onset type […] A drug discovered and advanced by The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science (IACS) […] Vapers using low rather than high nicotine e-cigarettes may be using their devices more intensely, potentially increasing the risk of […] A popular aquarium fish may hold answers to how tumors form in a childhood cancer. Muscle precursor cells called myoblasts […] Patient-derived organoids, hollow spheres of cells cultured from tumors, can quickly and accurately predict how patients with pancreatic cancer respond […] Our immune system’s arsenal of defenses usually protects us from cancer. But sometimes, cancer cells overwhelm or evade this elaborate […] Hematopoietic Stem Cells (HSCs) give rise to blood and immune cells of the body, and are therefore essential for our […]Lung Cancer
Molecular brake on human cell division prevents cancer
Drug compound stops cancer cells from spreading in mice
Diabetes may be an early manifestation of pancreatic cancer
Drug targets metabolic vulnerability and impairs cancer cell growth and survival: Pre-clinical results for IACS-10759 drug leads to Phase I clinical trials in AML and solid tumors
Ex-smokers might be better off with high rather than low nicotine e-cigs
Zebrafish expose tumor pathway in childhood muscle cancer
Organoid profiling identifies treatments for pancreatic cancer: They could be used to select the treatments most likely to work in specific patients
Two-pronged antibodies draw immune killers directly to cancer cells
A system of check and balances in the blood: How Hematopoietic Stem Cells manage to switch between activation and dormancy